Senior Clinical Evidence Leader

Teleflex; Leinster; Hybrid; EUR 90,000 - 130,000; Full time

Job summary

Teleflex is seeking a Senior Clinical Manager – Clinical Evidence Generation to lead the team delivering high-quality evidence that supports regulatory and business goals across anaesthesia, urology, and interventional urology portfolios.

The role provides scientific leadership for MDR clinical evidence activities (CERs, CEPs, PMCF, SSCPs) and strengthens Real-World Data capabilities, collaborating across Medical Affairs, Regulatory, Biostatistics, and Health Economics & Market Access.

Qualifications

• Strong leadership and cross-functional collaboration skills.
• Proven ability to generate clinical evidence and support regulatory decisions.
• Fluent written and spoken English with excellent scientific writing.

Responsibilities

• Lead the Clinical Evidence Generation team to deliver high-quality evidence for regulatory compliance.
• Provide scientific oversight of CERs, CEPs, PMCF, SSCPs and related activities.
• Strengthen RWD/RWE capabilities and advance evidence generation methodologies.
• Support Integrated Evidence Plans and collaborate with Medical Affairs, Regulatory, and RWE teams.
• Represent Teleflex in interactions with Notified Bodies and regulatory authorities.

Skills

Leadership

Clinical Evidence Generation

Regulatory Affairs

GCP & MDR knowledge

Study Design & Biostatistics

Real World Evidence (RWE)

Communication & Stakeholder mgmt

Education

Bachelor's in Life Sciences / Biomedical Engineering / Clinical Research / Epidemiology / Public Health

Master's or PhD preferred

Job description

Teleflex is seeking a Senior Clinical Manager – Clinical Evidence Generation to lead the team delivering high-quality evidence that supports regulatory and business goals across anaesthesia, urology, and interventional urology portfolios.

The role provides scientific leadership for MDR clinical evidence activities (CERs, CEPs, PMCF, SSCPs) and strengthens Real-World Data capabilities, collaborating across Medical Affairs, Regulatory, Biostatistics, and Health Economics & Market Access.